A subset of platinum-containing chemotherapeutic agents kills cells by inducing ribosome biogenesis stress-Reference-Cited by-同舟云学术

A subset of platinum-containing chemotherapeutic agents kills cells by inducing ribosome biogenesis stress

Published:2017-02-27 Issue:4 Volume:23 Page:461-471
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

Bruno Peter M^ORCID,Liu Yunpeng,Park Ga Young,Murai Junko,Koch Catherine E,Eisen Timothy J,Pritchard Justin R,Pommier Yves,Lippard Stephen J,Hemann Michael T

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://www.nature.com/articles/nm.4291.pdf

Reference67 articles.

1. Kelland, L. The resurgence of platinum-based cancer chemotherapy. Nat. Rev. Cancer 7, 573–584 (2007).

2. Chu, E. & v DeVita Jr, V.T. Physician's Cancer Chemotherapy Drug Manual (Jones & Bartlett Learning Oncology, Sudbury, 2008).

3. Rixe, O. et al. Oxaliplatin, tetraplatin, cisplatin, and carboplatin: spectrum of activity in drug-resistant cell lines and in the cell lines of the National Cancer Institute's Anticancer Drug Screen panel. Biochem. Pharmacol. 52, 1855–1865 (1996).

4. Machover, D. et al. Two consecutive phase II studies of oxaliplatin (L-OHP) for treatment of patients with advanced colorectal carcinoma who were resistant to previous treatment with fluoropyrimidines. Ann. Oncol. 7, 95–98 (1996).

5. Jiang, H., Pritchard, J.R., Williams, R.T., Lauffenburger, D.A. & Hemann, M.T. A mammalian functional-genetic approach to characterizing cancer therapeutics. Nat. Chem. Biol. 7, 92–100 (2011).

Cited by 407 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bridging pyrimidine hemicurcumin and Cisplatin: Synthesis, coordination chemistry, and in vitro activity assessment of a novel Pt(II) complex;Journal of Inorganic Biochemistry;2024-11

2. WDR68 stimulates cellular proliferation via activating ribosome biogenesis in 293T cells;Neoplasia;2024-10

3. ATR/Chk1 interacting lncRNA modulates DNA damage response to induce breast cancer chemoresistance;Cell Insight;2024-10

4. What is the Reason That the Pharmacological Future of Chemotherapeutics in the Treatment of Lung Cancer Could Be Most Closely Related to Nanostructures? Platinum Drugs in Therapy of Non-Small and Small Cell Lung Cancer and Their Unexpected, Possible Interactions. The Review;International Journal of Nanomedicine;2024-09

5. Blocking of SIRT7/FOXO3a Axis by miR-152-3p Enhances Cisplatin Sensitivity in Breast Cancer;The American Journal of the Medical Sciences;2024-09